The American health insurance system is no longer a neutral mechanism for spreading risk or paying for care. It has become a finely tuned profit machine—engineered by massive, multi-billion-dollar insurance conglomerates that have vertically integrated nearly every step of the health care journey. These corporations inflate prices, restrict access, delay care, and extract enormous profits, while families, employers, and taxpayers are left holding the bag.
Every year, the pattern is the same. Tens of millions of Americans pay more and get less: higher premiums, narrower networks, longer delays for care, greater confusion about coverage, and escalating out-of-pocket costs. Patients get the bills. Corporate executives get the bonuses. Share prices climb. And Washington mostly looks the other way.
That dynamic is finally being challenged. The Trump Administration has put insurance giants on notice, calling out hidden pricing schemes, sky-high premiums, and anti-competitive practices that enrich insurers at the expense of patients. But executive branch pressure alone is not enough. If Congress is serious about lowering costs in 2026, meaningful insurance reform cannot remain optional—it must be a top priority.
At the heart of the problem is vertical integration. UnitedHealth Group alone controls more than 2,600 subsidiaries, spanning insurance, physician groups, pharmacies, pharmacy benefit managers (PBMs), and data firms. How can Americans have fair access to care when a single company controls nearly every gate, decision, and dollar along the way? United is not an outlier—it is the model. The ten largest insurers dominate most of the national market. Blue Cross Blue Shield plans alone control roughly 43 percent of the commercial market and are the largest carrier in 84 percent of metro areas.
By federal antitrust standards, roughly three-quarters of county-level insurance markets are “highly” or “very highly” concentrated. In many states, one insurer controls more than half of the small-group or individual market; in some, that share exceeds 80 or even 90 percent. Alabama, Kentucky, Hawaii, Michigan, Louisiana, and Illinois are among the least competitive markets in the country. This is not a functioning marketplace—it is a rigged one.
The consolidation doesn’t stop with insurance. The same conglomerates that own insurers also own PBMs, group purchasing organizations, and specialty and mail-order pharmacies. The “big three” PBMs—nearly all insurance-affiliated—control about 80 percent of the prescription drug market. PBM-affiliated pharmacies dominate specialty and mail-order dispensing, marking up some generic specialty drugs by more than 1,000 percent. Patients are steered into corporate silos, while costs are quietly shifted onto families.
The results are devastating. Average family premiums for employer coverage now approach $24,000 a year—costs largely set by insurers and their PBMs. Deductibles have nearly quadrupled since the mid-2000s. Four in ten insured adults delay or skip care because of cost. In 2024, about 30 million Americans borrowed more than $74 billion to pay medical bills. Meanwhile, the largest insurers took in over $71 billion in profits in a single year, and top executives collected a combined $146 million in compensation.
Medicare Advantage exposes this dysfunction in its most cynical form. Sold to seniors as “better Medicare,” it is built to pay insurers more while providing less access to care. In 2023 alone, Medicare Advantage plans made nearly 50 million prior authorization determinations, delaying or denying care doctors had already prescribed. More than half of Part D drugs in these plans are subject to utilization management tools like prior authorization or step therapy. When patients do appeal denials, roughly 80 percent are overturned—clear evidence that many initial denials were inappropriate. But most seniors never appeal. Insurers count on that.
This is not efficiency. It is denial as a business strategy.
Across the system, insurance barriers are now the norm. Prior authorization, restrictive formularies, and narrow networks are no longer about managing care—they are levers to maximize rebate and spread revenue. Nearly 60 percent of insured adults report a serious problem with their insurer in the past year. Doctors and their staff spend an average of 13 hours per week on prior authorization paperwork instead of caring for patients. ACA exchange plans often include only one-third to one-half of local providers, forcing patients to travel farther, switch doctors, or simply go without care.
Affordability is now the number one problem in health care. By 2032, families could spend up to 40 percent of their income on health insurance alone. At the same time, taxpayers are subsidizing this broken system at staggering levels. ACA subsidies will cost $1.3 trillion over the next decade, with taxpayers now covering more than 90 percent of premiums. Medicare Advantage alone is estimated to generate over $1 trillion in waste. Yet insurers still demand more subsidies, more bailouts, and less oversight.
This cannot continue.
Real reform means severing the link between PBM profits and drug list prices. It means full transparency and mandatory pass-through of rebates and discounts to patients. It means enforcing competition policy to unwind harmful consolidation and restore real choice in plans, providers, and pharmacies. Most of all, it means realigning incentives so insurers and middlemen win only when patients do.
The system has gone off the rails: runaway premiums, constant denials, and zero accountability. Congress must start putting patients back at the center of health care. Insurance reform is long overdue. In 2026, it cannot wait any longer.
Author: Richard Inglis — Retired Healthcare Professional –Sun City Florida
Please make a small donation to the Tampa Free Press to help sustain independent journalism. Your contribution enables us to continue delivering high-quality, local, and national news coverage.
Sign up: Subscribe to our free newsletter for a curated selection of top stories delivered straight to your inbox
